Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

632 ! Thu, 8/2/2018, 8:30 AM - 10:20 AM CC-West 115
Statistical Issues Specific the Therapeutic Areas-4 — Contributed Papers
Biopharmaceutical Section
Chair(s): Wen-Chi Wu, Merck
8:35 AM Variational Inference for Proportional Hazards Model with Power Prior in Oncology Studies

Bo Jin, Boston Biomedical Inc.; Yue Chang, Boston Biomedical Inc
8:50 AM Utilization of Historical Data and Real World Evidence in Clinical Trial Development - Case Studies in Rare Disease and Oncology
Florence H Yong, Pfizer Inc.; Ray Li, Pfizer Inc.; Steven Y Hua, Celgene - Receptos; Jeffery Palmer, Pfizer Inc.; Roberto Bugarini, Pfizer Inc.
9:05 AM Mathematical Modeling Identifies Optimum Lapatinib Dosing Schedules for the Treatment of Glioblastoma Patients

Shayna Stein, Harvard University; Franziska Michor, Dana Farber Cancer Institute
9:20 AM Evaluation of Statistical Methods for Survival Analysis with Time-Dependent Variables

Chris Holland, Amgen; Qui Tran, Amgen; Cassie Dong, Amgen
9:35 AM Predicting the Long-Term Exposure in Acute Treatment of Migraine Using a Nonhomogeneous Poisson Process with Random Effects
Kaifeng Lu
9:50 AM Statistical Challenges and Opportunities in Drug Development for Rare Diseases

Guowen Sun, BioMarin; Keith Gregg, BioMarin; Peter Slasor, BioMarin; Chito Hernandez, BioMarin Pharmaceutical Inc.
10:05 AM Optimal Treatment Recommendation via Subgroup Identification in Randomized Control Trials

Yang (Grace) Zhao, Gilead Sciences; Haoda Fu, Eli Lilly and Company